Senior notes are a type of loan that a company borrows from investors, promising to pay it back with interest. They are called "senior" because in case the company faces financial trouble, these lenders are paid back before others. This makes senior notes safer for investors compared to other types of loans or bonds.
prospectus supplementregulatory
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
shelf registration statementregulatory
A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.
form s-3asrregulatory
Form S-3ASR is a type of SEC registration that lets large, well-known public companies pre-register securities so they can be sold quickly when needed, similar to having a pre-approved credit line they can draw on at short notice. For investors, it matters because it signals a company's readiness to raise cash fast, which can affect share supply and price (dilution) and reveal how easily the company can fund growth or handle short-term needs.
issuer free writing prospectusregulatory
An issuer free writing prospectus is any written communication produced by a company that supplements the formal securities prospectus when offering stock or bonds, but is not part of the long statutory prospectus document. Investors should care because these shorter, flexible documents—like a quick brochure or slide deck—can highlight key facts or updates that affect valuation or risk, so they can influence buying decisions and must be reviewed alongside the formal prospectus for a complete picture.
See more from StockTitan in Google Search and AI answers.Adds StockTitan as a preferred source · opens Google
EVERETT, Wash.--(BUSINESS WIRE)--
Fortive Corporation (“Fortive”) (NYSE: FTV) today announced that it has priced its registered offering (the “offering”) of $600 million aggregate principal amount of its 4.750% Notes due 2031 (the “2031 notes”) and $500 million aggregate principal amount of its 5.250% Notes due 2036 (the “2036 notes” and, together with the 2031 notes, the “notes”). The 2031 notes will bear interest at 4.750% per annum and mature on May 15, 2031, and the 2036 notes will bear interest at 5.250% per annum and mature on May 15, 2036. Interest on the notes will be paid semi-annually in arrears on May 15 and November 15 of each year, beginning on November 15, 2026. Fortive intends to use the net proceeds from the offering to refinance certain indebtedness, including the repayment at maturity of its 3.150% Senior Notes due June 15, 2026 (plus accrued and unpaid interest thereon), to pay related fees and expenses, and for general corporate purposes. The sale of the notes is expected to close on or about May 14, 2026, subject to customary closing conditions.
Morgan Stanley & Co. LLC, Barclays Capital Inc., J.P. Morgan Securities LLC and Scotia Capital (USA) Inc. are acting as joint book-running managers for the offering of the notes.
This offering is being made only by means of a prospectus supplement and the accompanying prospectus related to the offering of the notes (collectively, the “prospectus”). The notes will be issued pursuant to an effective shelf registration statement on Form S-3ASR previously filed by Fortive with the U.S. Securities and Exchange Commission (the “SEC”). Before you invest, you should read the prospectus and other documents Fortive has filed with the SEC for more complete information about Fortive and this offering. The preliminary prospectus supplement and an issuer free writing prospectus have been, and the final prospectus supplement will be, filed with the SEC and are and will be available on the SEC’s website at www.sec.gov. Alternatively, copies of the prospectus, preliminary prospectus supplement and, when available, the final prospectus supplement related to this offering may be obtained by contacting Morgan Stanley & Co. LLC at +1-866-718-1649; Barclays Capital Inc. at +1-888-603-5847; J.P. Morgan Securities LLC at +1-212-834-4533; and Scotia Capital (USA) Inc. at +1-800-372-3930.
This press release is for informational purposes only and shall not constitute an offer to sell or a solicitation of an offer to buy the notes or any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offering, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
ABOUT FORTIVE
Fortive innovates essential technologies to keep our world safe and productive. Fortive’s strategic segments - Intelligent Operating Solutions and Advanced Healthcare Solutions - include iconic inventor brands with leading positions in their markets. The company’s businesses design, develop, manufacture, and market products, software, and services, building on leading brand names, innovative technologies, and strong market positions. Fortive is headquartered in Everett, Washington and employs a team of more than 10,000 research and development, manufacturing, sales, distribution, service, and administrative team members in approximately 50 countries around the world. With a culture rooted in continuous improvement, the core of our company’s operating model is the Fortive Business System.
FORWARD-LOOKING STATEMENTS
The release contains information about future expectations, plans and prospects of Fortive’s management that constitute forward-looking statements within the meaning of the U.S. federal securities laws, including statements with respect to Fortive’s expectations to complete the proposed offering and its intended use of proceeds therefrom. There can be no assurance that Fortive will be able to complete the proposed offering on the anticipated terms, or at all. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including, but not limited to, the terms of the offering, risks and uncertainties related to whether or not Fortive will consummate the offering, the impact of general economic, industry, market or political conditions and other factors that are discussed in Fortive’s SEC filings, including its Annual Report on Form 10-K for the year ended December 31, 2025 and its quarterly reports on Form 10-Q and other documents periodically filed with the SEC, all of which are available on the SEC’s website at www.sec.gov. These forward-looking statements speak only as of the date of this release, and Fortive does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.
